Extrawell Pharmaceutical Holdings Limited (HK:0858) has released an update.
Extrawell Pharmaceutical Holdings Limited has announced the composition of its Board of Directors, along with the roles and functions of each member. The Executive Directors are led by Dr. Xie Yi as Chairman and CEO, with a team comprising both executive and independent non-executive members. Additionally, the company has detailed the membership of its three key Board committees: Audit, Remuneration, and Nomination.
For further insights into HK:0858 stock, check out TipRanks’ Stock Analysis page.
